Overview
NICE is unable to recommend the use in the NHS of tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia because no evidence submission was received from the manufacturer of the technology.
Last reviewed: 23 January 2013
Next review: We will review this decision if the company decides to make a submission.